- Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Comparative Bioavailability and Bioequivalence of Oxazepam 10 mg Orodispersible Tablets (Test) Versus Seresta® 10 mg Tablets (Reference): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects
This study is checking if a new 10mg oxazepam tablet works the same way in the body as an existing one. It's for healthy adults and helps ensure new medicines are just as effective and safe as older ones before being widely used.
For: No medical condition is being investigated. This is a comparative bioavailabilty study.Portugal - Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Comparative Bioavailability and Bioequivalence of Oxazepam 50 mg Orodispersible Tablets (Test) Versus Seresta® 50 mg Tablets (Reference): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects
This study is comparing two versions of a 50mg oxazepam tablet: our new dissolving tablet and the existing Seresta® tablet. We want to see if the new tablet works in the body in a similar way to the old one. This helps us ensure it's safe and effective.
For: No medical condition is being investigated. This is a comparative bioavailability study.Portugal